Cargando…
Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening
Human induced pluripotent stem cells (hiPSCs) have emerged as a novel tool for drug discovery and therapy in cardiovascular medicine. hiPSCs are functionally similar to human embryonic stem cells (hESCs) and can be derived autologously without the ethical challenges associated with hESCs. Given the...
Autores principales: | Sharma, Arun, Wu, Joseph C, Wu, Sean M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056681/ https://www.ncbi.nlm.nih.gov/pubmed/24476344 http://dx.doi.org/10.1186/scrt380 |
Ejemplares similares
-
Partial Reprogramming of Pluripotent Stem Cell-Derived Cardiomyocytes into Neurons
por: Chuang, Wenpo, et al.
Publicado: (2017) -
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function
por: Wnorowski, Alexa, et al.
Publicado: (2019) -
Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening
por: Ovics, Paz, et al.
Publicado: (2020) -
Accurate nanoelectrode recording of human pluripotent stem cell-derived cardiomyocytes for assaying drugs and modeling disease
por: Lin, Ziliang Carter, et al.
Publicado: (2017) -
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease Modeling
por: Bayzigitov, Daniel R., et al.
Publicado: (2016)